Secondary Logo

April 2019 - Volume 25 - Issue 3
pp: 115-155,e1-e34

Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety

Bird, Paul; Bensen, William; El-Zorkany, Bassel; More

JCR: Journal of Clinical Rheumatology. 25(3):115-126, April 2019.

Planning for the Rheumatologist Workforce: Factors Associated With Work Hours and Volumes

Barber, Claire E. H.; Nasr, Mina; Barnabe, Cheryl; More

JCR: Journal of Clinical Rheumatology. 25(3):142-146, April 2019.

Clinical Profile of Levamisole-Adulterated Cocaine-Induced Vasculitis/Vasculopathy: A 30-Case Series

Muñoz-Vahos, Carlos Horacio; Herrera-Uribe, Sebastián; Arbeláez-Cortés, Álvaro; More

JCR: Journal of Clinical Rheumatology. 25(3):e16-e26, April 2019.